Go Beyond the Hype and GMP
The first rule of IPO investing is to look past the media frenzy and the Grey Market Premium (GMP). GMP is an unofficial, unregulated indicator of listing price expectations and can be highly volatile. Similarly, high subscription figures only show crowd
interest, not company quality. Many heavily subscribed IPOs have listed below their issue price in the past. Instead of relying on this speculative buzz, your first step should be independent research. The goal isn't just to snag listing gains, which can be unpredictable, but to assess if the company is a worthwhile long-term investment.
Decode the Prospectus (DRHP)
Every company planning an IPO files a Draft Red Herring Prospectus (DRHP) with SEBI. This document, often running into hundreds of pages, is your single most important resource. Don't be intimidated; focus on a few key sections. Start with 'About the Company' to understand its business model and 'Industry Overview' to gauge its market position. Crucially, read the 'Risk Factors' section, as it legally requires the company to disclose potential threats to its business, such as high debt, customer concentration, or pending legal cases. This section often provides a more realistic picture than marketing materials.
Scrutinise the Financial Health
A company's financial statements tell the story of its performance. Look for consistency over the past three years. Key metrics to check include revenue growth, profit after tax (PAT), and cash flow from operations. A sudden spike in profits right before an IPO can be a red flag. Healthy cash flow from operations is vital, as it proves the company generates real cash, not just 'paper profits'. Also, check the debt-to-equity ratio; high leverage can be risky. Since 2022, SEBI has mandated that companies disclose and compare these Key Performance Indicators (KPIs) against their listed peers, making your analysis easier.
Understand the 'Why' Behind the IPO
The DRHP's 'Objects of the Offer' section reveals why the company is raising money. Is it for expansion, innovation, and entering new markets? That's generally a positive sign. Or is it primarily to repay old debt or allow existing investors and promoters to sell their shares (an Offer for Sale or OFS)? While an OFS is not inherently bad, a large OFS component might suggest that early backers are cashing out, which warrants a closer look at their reasons for exiting. A healthy mix of fresh issue for growth and a smaller OFS is often seen as more favourable.
Evaluate the Management Team
An investment in a company is an investment in its leadership. The prospectus provides detailed backgrounds of the promoters and key management personnel. Look for experience and a solid track record in their industry. The document will also disclose any pending criminal cases or significant litigation against the promoters, which is a critical check for corporate governance standards. A strong, stable, and transparent management team is often a key ingredient for long-term success.
Assess the Valuation
Finally, a great company can be a bad investment if the price is too high. Valuation is about determining if the IPO is priced fairly. Compare its price-to-earnings (P/E) ratio, price-to-book (P/B) ratio, and return on equity (RoE) with those of its listed competitors. If the IPO is priced at a significant premium to its peers without a clear justification (like much higher growth rates), it might be overvalued. Young, loss-making tech startups might not have a P/E ratio, so for them, you might need to look at other metrics like price-to-sales or EV/EBITDA and compare them to industry benchmarks.
